These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 8309316
1. Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats. Lee KC, Silver PJ, Bode DC, Gherezghiher T. Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):527-34. PubMed ID: 8309316 [Abstract] [Full Text] [Related]
2. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Ogidigben MJ, Chu TC, Potter DE. Exp Eye Res; 2001 Mar; 72(3):331-9. PubMed ID: 11180982 [Abstract] [Full Text] [Related]
3. Nitrovasodilators as a new class of ocular hypotensive agents. Nathanson JA. J Pharmacol Exp Ther; 1992 Mar; 260(3):956-65. PubMed ID: 1532035 [Abstract] [Full Text] [Related]
4. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Tokushige H, Inatani M, Nemoto S, Sakaki H, Katayama K, Uehata M, Tanihara H. Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3216-22. PubMed ID: 17591891 [Abstract] [Full Text] [Related]
5. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4). Bivalacqua TJ, Champion HC, Rajasekaran M, Sikka SC, Kadowitz PJ, Doherty PC, Hellstrom WJ. J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946 [Abstract] [Full Text] [Related]
6. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Russell KR, Wang DR, Potter DE. Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526 [Abstract] [Full Text] [Related]
7. The effect of intravitreal and topical prostaglandins on intraocular inflammation. Kulkarni PS, Srinivasan BD. Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):383-92. PubMed ID: 7050005 [Abstract] [Full Text] [Related]
8. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes. Nishio M, Fukunaga T, Sugimoto M, Ikesugi K, Sumi K, Hidaka H, Uji Y. Curr Eye Res; 2009 Apr; 34(4):282-6. PubMed ID: 19373576 [Abstract] [Full Text] [Related]
9. Contributions of adenosine receptor activation to the ocular actions of epinephrine. Crosson CE, Petrovich M. Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2054-61. PubMed ID: 10440261 [Abstract] [Full Text] [Related]
10. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion. Brechue WF, Maren TH. Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174 [Abstract] [Full Text] [Related]
11. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys. Gabelt BT, Robinson JC, Hubbard WC, Peterson CM, Debink N, Wadhwa A, Kaufman PL. Exp Eye Res; 1994 Dec; 59(6):633-44. PubMed ID: 7698258 [Abstract] [Full Text] [Related]
12. Effects of systemic administration of 0.5% tropicamide on intraocular pressure, pupillary diameter, blood pressure, and heart rate in normal cats. Schmidt KS, Hacker DV, Kass PH, Barkhoodarian AL. Vet Ophthalmol; 2006 Dec; 9(2):137-9. PubMed ID: 16497239 [Abstract] [Full Text] [Related]
13. Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy. Straznicka M, Leone RJ, Scholz PM, Weiss HR. J Surg Res; 1998 Apr; 76(1):61-6. PubMed ID: 9695741 [Abstract] [Full Text] [Related]
14. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye. Stadtbäumer K, Frommlet F, Nell B. Vet Ophthalmol; 2006 Apr; 9(4):233-7. PubMed ID: 16771758 [Abstract] [Full Text] [Related]
15. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582. Pagani ED, Dundore RL, Bode DC, Bacon ER, Singh B, Lesher GY, Buchholz RA, Silver PJ. J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296 [Abstract] [Full Text] [Related]
16. Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion. Chiu T, Reid IA. J Pharmacol Exp Ther; 1996 Aug; 278(2):793-9. PubMed ID: 8768733 [Abstract] [Full Text] [Related]
17. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats. Miller PE, Rhaesa SL. Am J Vet Res; 1996 Jan; 57(1):83-6. PubMed ID: 8720244 [Abstract] [Full Text] [Related]
18. Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes. Regnier A, Lemagne C, Ponchet A, Cazalot G, Concordet D, Gelatt KN. Vet Ophthalmol; 2006 Jan; 9(1):39-43. PubMed ID: 16409244 [Abstract] [Full Text] [Related]
19. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs. Lee KC, Clas DM, Gorczyca WP, Silver PJ, Ezrin AM. Drugs Exp Clin Res; 1991 Jan; 17(7):323-36. PubMed ID: 1686584 [Abstract] [Full Text] [Related]
20. Iloprost, a stable prostacyclin analog, reduces intraocular pressure. Hoyng PF, de Jong N. Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):470-6. PubMed ID: 2435669 [Abstract] [Full Text] [Related] Page: [Next] [New Search]